Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_provenance.
- NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_assertion description "[According to the LOH study at intragenic polymorphic sites, deletion of Bcl10 in informative cases was detected in 50% of malignant mesotheliomas, 33% of gastric carcinomas, 23% of breast carcinomas, 20% of hepatocellular carcinomas, 17% of lymphomas, 15% of colorectal carcinomas, 13% of laryngeal carcinomas, and 10% of male germ cell tumors (GCTs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_provenance.
- NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_assertion evidence source_evidence_literature NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_provenance.
- NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_assertion SIO_000772 10582682 NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_provenance.
- NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_assertion wasDerivedFrom befree-2016 NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_provenance.
- NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_assertion wasGeneratedBy ECO_0000203 NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_provenance.
- befree-2016 importedOn "2016-02-19" NP268834.RAuD5HsNdHUTwYvx_GYC1uFrdHtiJzFCjd2WV4GHDF-Bo130_provenance.